NFKB1 and hematocrit: We found that CD21 protected against tPA-induced HT in tMCAO mice, reflected by improvements in cerebral hemorrhage and injury, BBB disruption, cytokine transcription, glial cell activation, MAFB/MSR1-mediated Prx1 clearance, and TLR4/NF-κB pathway inhibition.